Long COVID inflammation damages the heart, study finds

Recent research from the University of Queensland has identified inflammatory markers in the blood of long COVID patients, shedding light on the cardiovascular issues many experience post-infection. The study, led by Associate Professor Kirsty Short, focused on understanding the persistent chest pain and heart palpitations reported by long COVID sufferers. The findings revealed elevated levels of cytokines—proteins that regulate inflammation—present in individuals approximately 18 months after contracting SARS-CoV-2, indicating a potential link between chronic inflammation and heart-related symptoms.

The research involved analyzing blood samples from 50 participants, including those with long COVID, those who had recovered from COVID, and individuals who had never been infected. Utilizing advanced nanotechnology, the team detected trace levels of cytokines and markers of cardiac tissue damage. The results suggest that these elevated cytokines may impair the function of cardiomyocytes, the heart's pumping cells, thereby contributing to the cardiovascular symptoms observed in long COVID patients. This connection between chronic inflammation and heart health had not been clearly established before this study.

While the findings provide valuable insights into the complexities of long COVID, further validation in larger patient cohorts is necessary. The researchers are also interested in exploring whether these results could extend to other long COVID symptoms, such as neurological or respiratory issues. This collaborative effort among various institutions aims to enhance the understanding, diagnosis, and treatment of long COVID, potentially leading to improved patient outcomes in the future.